CBD Bioavailability by Delivery Method: Vapes vs Tinctures vs Gummies

What Is Bioavailability, and Why Does It Matter?

Bioavailability is the proportion of a substance that reaches your systemic circulation (your bloodstream, in other words) in an active, unchanged form. It’s expressed as a percentage. A drug given intravenously has 100% bioavailability by definition, because it goes directly into the blood. Every other route of administration (oral, inhaled, sublingual, topical) delivers less than 100% and the exact percentage depends on how much of the dose gets absorbed and how much survives the trip.

For CBD, bioavailability matters in two concrete ways:

1. Label dose is not body dose. A 25mg gummy does not give your body 25mg of CBD. It gives you roughly 1 to 5mg depending on conditions. Dosing calculations that treat the label number as the blood level are wrong
2. Products at the same label dose feel different. Two 25mg CBD products with different delivery methods can produce noticeably different subjective effects because one delivers five times more active CBD to your blood than the other

The primary academic reference for this entire topic is a 2018 systematic review by Millar, Stone, Yates, and O’Sullivan in Frontiers in Pharmacology (Volume 9, Article 1365). They analyzed 24 pharmacokinetic studies of CBD in humans and documented half-life ranges, peak plasma concentrations, and bioavailability estimates across multiple routes. It’s the canonical citation most other CBD articles should (and don’t always) point to.

---

The First-Pass Metabolism Problem

Before we break down each delivery method, one piece of physiology makes the whole picture make sense: the liver’s first-pass metabolism.

When you swallow a CBD gummy, the CBD goes through your stomach, gets absorbed in the small intestine, and enters your portal venous blood. That blood drains directly into your liver before it reaches the rest of your body. In the liver, a family of enzymes called cytochrome P450 (primarily CYP3A4 and CYP2C9 for CBD) metabolize a large portion of the CBD before it can leave the liver and enter systemic circulation. That’s first-pass metabolism. It’s the same process that makes oral delta-9 THC edibles take so long to hit, and the same process that creates the 11-hydroxy-THC metabolite that makes edibles feel different from smoked cannabis.

First-pass metabolism is why oral CBD has such low bioavailability. Most of the CBD never gets to your blood intact. Routes that bypass the digestive tract (inhalation, sublingual, topical, transdermal) skip the first-pass and deliver more CBD to circulation per milligram consumed. That’s the single biggest variable behind why different delivery methods produce such different effective doses.

---

Method 1: Inhalation (Vapes and Smoking)

Bioavailability: 34 to 56%
Onset: 2 to 10 minutes
Duration: 2 to 3 hours

Inhalation is the highest-bioavailability delivery method by a wide margin. When you inhale CBD vapor or smoke, the CBD crosses from the alveoli in your lungs directly into your pulmonary capillaries, then into your heart, and from there to the rest of your body within seconds. There’s no first-pass metabolism because the blood leaving the lungs doesn’t go through the liver first.

The range (34 to 56%) reflects variation across studies and across device types. High-quality vaporizers with precise temperature control tend to sit at the high end. Combustion (smoking) sits lower, both because some CBD is destroyed by heat and because deeper inhalation patterns and breath-hold times vary between users. McGilveray’s 2005 pharmacokinetic review in Pain Research and Management reported similar patterns for inhaled cannabinoids more broadly, with smoked THC averaging around 30% bioavailability and considerable inter-individual variation.

Inhalation is the method of choice when you need fast onset. Most people feel effects within 5 to 10 minutes, and you can titrate dose in real time by taking additional puffs. The trade-off is duration: the effects fade relatively quickly, typically within 2 to 3 hours for a single session.

Health context for inhalation

Smoking any plant material exposes your lungs to combustion byproducts, including tar and polycyclic aromatic hydrocarbons. Vaping CBD oil avoids most combustion but introduces its own considerations (thinning agents, heating-element compatibility, device quality). If you’re using inhaled CBD regularly, look for clean vape formulations that use hemp-derived terpenes and avoid propylene glycol-heavy dilutents. Our CBD vape cartridge collection is built for this reason.

---

Method 2: Sublingual (Tinctures and Oils)

Bioavailability: 12 to 35%
Onset: 15 to 45 minutes
Duration: 4 to 6 hours

Sublingual administration is the middle ground between inhalation and oral. When you hold a CBD tincture under your tongue for 60 to 90 seconds before swallowing, some of the CBD absorbs through the highly vascularized mucous membranes in your mouth and enters systemic circulation directly, bypassing the liver.

The catch: most people don’t actually use tinctures sublingually. They drop the oil on their tongue, swallow immediately, and effectively convert the tincture into an oral dose. If you want the sublingual bioavailability advantage, you have to hold it under the tongue. The longer you hold it (up to about 90 seconds), the more absorbs through the oral mucosa. Whatever isn’t absorbed sublingually gets swallowed and enters the normal oral pathway, so you get a mix of both routes.

Tinctures are the most flexible dosing format. You can measure single-milligram precision using the dropper, adjust up or down easily, and get a middle-ground onset that’s faster than gummies but not as immediate as vaping. The primary downsides are the hemp taste (mitigated with flavored formulations) and the discipline required to actually hold the dose under the tongue.

MCT oil and absorption

Most CBD tinctures use MCT (medium-chain triglyceride) oil as a carrier. MCT is chosen because it’s well-tolerated, flavor-neutral, and may slightly improve CBD absorption by keeping the lipophilic CBD molecule dissolved and bioavailable to mucosal tissue. The research on MCT versus other carrier oils for CBD specifically is limited, but MCT is the standard for practical reasons.

---

Method 3: Oral (Gummies, Capsules, Beverages)

Bioavailability: 4 to 20% (most sources report 6 to 13% average)
Onset: 30 to 120 minutes
Duration: 4 to 8 hours

Oral CBD is the most consumed form because it’s the most convenient (no holding, no inhaling, just chew and swallow). It’s also the lowest-bioavailability method because it runs headlong into the first-pass metabolism problem described above. Most of the CBD you swallow either doesn’t get absorbed from the gut or gets metabolized in the liver before reaching systemic circulation.

The bioavailability range is wide because several variables affect absorption:

• Formulation matters. A gummy with the CBD simply mixed into the base has lower bioavailability than a gummy where the CBD is formulated with emulsifiers or in a lipid carrier
• Food effect is large. Consuming CBD with a high-fat meal can substantially increase absorption, sometimes more than doubling total exposure compared to a fasted state
• Individual CYP enzyme activity varies. People with slower CYP3A4 or CYP2C9 activity clear less CBD during first-pass, which raises their effective bioavailability

Oral CBD has the longest duration of the common methods. Because absorption is slow and metabolism is gradual, effects typically last 4 to 8 hours or more. That’s part of the appeal for evening use or sustained-throughout-the-day dosing.

The honest commercial note: the low-bioavailability reality is why most consumer CBD gummies in the 10 to 25mg range produce inconsistent subjective effects. When only 6 to 13% of the label dose is actually getting into your blood, you’re working with 1 to 3mg effective doses. That’s at or below the threshold where most people notice anything.

---

Method 4: Topical (Creams and Lotions)

Systemic bioavailability: less than 1%
Local onset: 15 to 60 minutes
Local duration: varies, typically hours

Topical CBD is a different category. Standard creams, lotions, salves, and balms are not designed to deliver systemic CBD. They’re designed to deliver localized effect at the application site, where the CBD interacts with cannabinoid receptors in the skin and superficial tissues.

CBD is strongly lipophilic (fat-soluble) with a log-p in the 6 to 7 range, which means it doesn’t cross the aqueous outer layer of skin easily. Standard topical formulations tend to keep the CBD in the stratum corneum and underlying layers without reaching the bloodstream. That’s fine if your goal is localized effect (muscle soreness, joint discomfort, skin-level support) but it’s the wrong delivery method if you’re trying to influence the whole body.

If a topical advertises “systemic bioavailability,” that’s a red flag unless the product is a specialized transdermal system (next section). Standard creams are local-only by design.

---

Method 5: Transdermal (Patches)

Systemic bioavailability: variable, product-specific
Onset: slow, gradual
Tmax (time to peak blood level): up to 38 hours post-application

Transdermal patches are distinct from standard topicals. They’re formulated with permeation enhancers (often ethanol, oleic acid, or proprietary delivery systems) specifically designed to push cannabinoids through the skin barrier and into systemic circulation. A 2022 exploratory study on a novel transdermal CBD/THC delivery system in Advances in Therapy found that time to peak plasma concentration can extend up to 38 hours after application, with a smaller maximum concentration than what inhaled or oral dosing produces but with much longer steady-state plasma levels.

The practical use case for transdermal CBD is prolonged, consistent dosing without peaks and valleys. You apply the patch, it delivers cannabinoids into your bloodstream over many hours, and you get a flatter pharmacokinetic curve than any oral or inhaled dose could produce. The trade-off: slow onset and the product-quality question (well-designed patches are expensive and uncommon; poorly designed patches function more like topicals).

---

Side-by-Side Method Comparison

Method	Bioavailability	Onset	Peak	Duration	Primary Use Case
Inhalation	34-56%	2-10 min	15-30 min	2-3 hr	Fast relief, precise titration
Sublingual	12-35%	15-45 min	1-2 hr	4-6 hr	Precise dosing, middle-ground speed
Oral (edibles)	4-20%	30-120 min	2-4 hr	4-8 hr	Long-lasting, convenient
Topical	<1% systemic	15-60 min (local)	Varies	Hours (local)	Localized effect only
Transdermal patch	Product-specific	Hours	Up to 38 hr	24+ hr	Sustained steady-state delivery

---

Factors That Change Your Personal Bioavailability

The percentages above are population averages from clinical studies. Your individual bioavailability on any given dose depends on several variables.

• Food, especially fat content. A high-fat meal can substantially increase oral CBD absorption. For oral CBD you actually want to eat something fatty, the opposite of what you’d do with most medications
• Body composition. CBD is lipophilic and distributes into fat tissue. Higher body fat percentage means more of the absorbed CBD gets sequestered into adipose storage rather than circulating to receptors
• Liver enzyme activity. CYP3A4 and CYP2C9 variability (genetic and drug-induced) changes how much first-pass metabolism removes before the CBD reaches circulation
• Drug interactions. CBD inhibits CYP3A4 and CYP2C9 itself, which can raise blood levels of medications that use those enzymes. That same inhibition, applied to CBD’s own metabolism, means co-administration with certain drugs can raise CBD’s effective bioavailability
• Inhalation technique. Deep, slow inhalation with 3 to 5 second breath-hold maximizes alveolar absorption. Shallow, fast puffs deliver less
• Formulation quality. Nanoemulsions, liposomes, and self-emulsifying drug delivery systems can improve oral bioavailability. So can MCT-based carrier oils in tinctures. Product formulation matters as much as route
• Tolerance. Regular CBD use can upregulate CYP450 enzyme activity, increasing clearance and reducing perceived effects over time. Tolerance breaks (2 to 4 weeks) can reset this

The practical implication: if you’re trying to compare products or figure out what dose you actually need, treat the label number as a starting point and adjust based on what you observe, not what you expect.

---

Dose Equivalence Across Methods

How do you translate a dose from one method to another? There isn’t a clinical-grade answer, but you can make reasonable approximations using the midpoint of each bioavailability range.

If you take this…	Approximate blood CBD	Oral equivalent	Sublingual equivalent	Inhaled equivalent
25mg oral (gummy)	~2-3mg	25mg	10mg	5mg
25mg sublingual (tincture)	~6-7mg	60-75mg	25mg	12-15mg
25mg inhaled (vape)	~11-14mg	100-150mg	45-55mg	25mg

These are rough approximations. Individual bioavailability varies enough that the same label dose could produce 2x differences between two people using the same method. Use this as a directional tool, not a formula.

---

Which Method for Which Goal?

Different situations favor different delivery methods. A practical breakdown.

Choose inhalation (vape or flower) if:

• You need fast relief (less than 10 minutes to onset)
• You want to titrate dose in real time by taking additional puffs
• You’re dealing with an acute situation and don’t want to wait 90 minutes
• You’re okay with a shorter effect window (2 to 3 hours)
• You have healthy lungs and you’re comfortable with the respiratory route

Choose sublingual (tincture) if:

• You want the bioavailability advantage without inhaling
• You need precise, adjustable dosing (single-milligram increments)
• You’re comfortable with a 15 to 45 minute onset
• You want a middle-ground duration (4 to 6 hours)
• You can commit to holding the oil under your tongue for 60 to 90 seconds

Choose oral (gummy, capsule, beverage) if:

• You want the longest duration of any common method (4 to 8+ hours)
• You prefer the convenience and taste of a food-like product
• Slow onset is acceptable for your use case (evening wind-down, sustained dosing)
• You’re willing to dose higher to compensate for lower bioavailability
• You’ll take it with a fatty meal to improve absorption

Choose topical if:

• Your goal is localized effect (specific muscle, joint, or skin area)
• You don’t want any systemic CBD in your bloodstream
• You’re layering with another method for combined systemic + local approach
• Drug testing is a concern and you want to minimize systemic absorption risk

---

A Note on Nanoemulsions and “Enhanced” Bioavailability

Nanoemulsion CBD products (and adjacent technologies: liposomal CBD, water-soluble CBD, self-emulsifying drug delivery systems) are designed to improve the bioavailability of oral CBD by creating ultra-small droplets of CBD that disperse in water and are more easily absorbed from the gut.

The science is real. Properly formulated nanoemulsion CBD can have 2 to 4 times the oral bioavailability of standard oil-based CBD, which shifts the effective dose of a 25mg gummy from ~2-3mg bioavailable to ~6-10mg bioavailable. That’s a meaningful difference.

The challenge is verification. Most products labeled “nanoemulsion” or “water-soluble” aren’t independently tested for actual particle size or actual human bioavailability. Marketing claims run far ahead of the science for specific products. If a product is selling on “enhanced bioavailability,” look for:

• Particle size disclosure (true nanoemulsions are typically <200 nm)
• Independent pharmacokinetic testing results (not manufacturer claims)
• Third-party lab confirmation of formulation integrity
• Certificate of analysis showing the actual CBD content matches the label

Our guide on reading certificates of analysis walks through what to look for when evaluating any claimed formulation advantage.

---

---